Cenix, Cellcentric, AstraZeneca deal

Cenix announced a pair of service deals to use its high throughput RNAi assays with the Cellenger image analysis platform to discover and validate targets.

Cellenger was developed by Definiens AG (Munich, Germany), which co-markets the technology with Cenix under a 2005 deal (see BioCentury, May 16, 2005). ...